top of page
Beijing Puhua International Hospital Health Screening Packages Comparison
Compare the men’s and women’s health screening packages at Beijing Puhua International Hospital, priced at CNY 18,897 (Approx. $2,700 USD) and CNY 20,422 (Approx. $2,917 USD), respectively. Review laboratory tests, tumour marker panels, ultrasound, chest CT, brain MRI and MRA, ECG, and sedated gastroscopy and colonoscopy. Search the table or expand either package to see its complete list of examinations.
MedBridgeNZ assists international patients with enquiries, appointment coordination, translation and non-clinical travel logistics. Discuss test selection and package suitability with a qualified healthcare professional.
MedBridgeNZ package comparison
Health Screening Packages Comparison
Beijing Puhua International Hospital. Compare the men’s and women’s packages, total prices and complete test lists.
At-a-glance comparison
| Package | Price | Selected inclusions |
|---|---|---|
| Men’s Health Screening Package | CNY 18,897 (Approx. $2,700 USD) | Eye examination, laboratory tests, C12 tumour marker panel, ultrasound, chest CT, brain MRI + MRA, ECG, and sedated gastroscopy + colonoscopy. Men-specific items: free PSA, total PSA, free-to-total PSA ratio, and urinary system ultrasound. |
| Women’s Health Screening Package | CNY 20,422 (Approx. $2,917 USD) | Eye examination, laboratory tests, C12 tumour marker panel, ultrasound, chest CT, brain MRI + MRA, ECG, and sedated gastroscopy + colonoscopy. Women-specific items: gynaecological examination, TCT, HPV, CA125, CA15-3, CY211 (source label), breast ultrasound, and transvaginal ultrasound. |
Complete package details
Men’s Health Screening Package
CNY 18,897 (Approx. $2,700 USD)
Eye examination
- Eye examination package
- Visual acuity test
- Intraocular pressure measurement
- Computerised refraction and corneal curvature measurement
- Axial length measurement (optical biometry)
- Clinical refraction
- Fundus examination
- Macular optical coherence tomography (OCT)
Laboratory tests
- Five infectious disease tests
- Hepatitis A, hepatitis B, hepatitis C, syphilis and HIV.
- Routine urinalysis
- Hospital-listed purpose: May indicate urinary system disorders, including acute or chronic nephritis, pyelonephritis, cystitis, urethritis, nephrotic syndrome, lupus nephritis, haemoglobinuria, renal infarction, acute renal tubular necrosis caused by heavy metal salts or medications, kidney or bladder tumours, and glucose in the urine.
- Electrolyte panel (3 items)
- Hospital-listed purpose: To assess electrolyte metabolism disturbances associated with conditions such as kidney disease, diabetes and endocrine disorders.
- Kidney function panel (4 items)
- Hospital-listed purpose: May indicate impaired kidney function, including in conditions such as pyelonephritis, renal tuberculosis and kidney tumours.
- Liver function panel (9 items)
- Hospital-listed purpose: Sensitive indicators of liver cell injury. Elevated results may indicate liver or biliary disease, including acute infectious hepatitis, toxic hepatitis and drug-induced toxic hepatitis.
- Blood lipid panel (4 items)
- Hospital-listed purpose: Blood lipid concentrations are closely associated with cardiovascular and cerebrovascular disease and provide reference information for diagnosing atherosclerosis, coronary heart disease and nephrotic syndrome. The sheet also lists risk indication and diagnosis for atherosclerosis, hypertension, cerebrovascular disease, coronary heart disease, diabetes, obesity, hyperlipidaemia and nephrotic syndrome.
- Cardiac enzyme panel (4 items)
- Hospital-listed purpose: To assist in the diagnosis of myocardial infarction, myocarditis and other cardiac conditions.
- Calcium and phosphorus
- Hospital-listed purpose: To check for chronic kidney disease.
- Blood glucose
- Hospital-listed purpose: To assess low blood glucose, diabetes and blood glucose control.
- Carbon-14 urea breath test
- Hospital-listed purpose: To determine whether bacterial infection is present in the stomach; the sheet links this infection with gastritis and gastric cancer.
- Glycated haemoglobin (HbA1c)
- Hospital-listed purpose: Reflects average blood glucose levels over the preceding 2–3 months.
- Homocysteine
- Hospital-listed purpose: Mainly used to assess conditions such as coronary atherosclerotic heart disease, myocardial infarction and cerebral infarction.
- Coagulation panel (4 items)
- Hospital-listed purpose: Reflects coagulation function and is used to investigate thrombotic disease.
- Plasma D-dimer
- Hospital-listed purpose: To assess the risk of deep vein thrombosis.
- Thyroid function panel (7 items)
- Triiodothyronine (T3)
- Thyroxine (T4)
- Serum thyroid-stimulating hormone (TSH)
- Serum free T3
- Serum free T4
- Anti-thyroglobulin antibodies
- Anti-thyroid peroxidase antibodies
- Hospital-listed purpose: To assess thyroid function and thyroid autoimmune status.
Men’s C12 tumour marker panel
- Alpha-fetoprotein (AFP)
- Hospital-listed purpose: To assist in the diagnosis of liver cancer.
- Carcinoembryonic antigen (CEA)
- Hospital-listed purpose: Early diagnosis of rectal and colorectal cancer.
- Cancer antigen 19-9 (CA19-9)
- Hospital-listed purpose: Early diagnosis of digestive system disease, pancreatic cancer and biliary malignancies.
- Free prostate-specific antigen (f-PSA)
- Hospital-listed purpose: PSA circulating in the blood in its free form. The sheet describes its value for the diagnosis and differentiation of benign prostate disease and prostate cancer.
- Total prostate-specific antigen (t-PSA)
- Hospital-listed purpose: The sheet describes it as an important organ-specific tumour marker used for prostate cancer screening.
- Free-to-total PSA ratio (f-PSA/t-PSA)
- Hospital-listed purpose: The ratio is used to assess the nature of prostate tumours. The sheet states that a ratio above 25% suggests benign prostate disease, while a ratio below 25% indicates a high risk of prostate cancer.
- Cancer antigen 242 (CA242)
- Hospital-listed purpose: A broad-spectrum digestive tract tumour marker.
- Cancer antigen 50 (CA50)
- Hospital-listed purpose: An indicator for tumours including liver, lung, pancreatic, gastric, ovarian, gallbladder, breast, colon and rectal cancer. The sheet describes it as a non-specific, broad-spectrum tumour marker.
- Neuron-specific enolase (NSE)
- Hospital-listed purpose: The sheet describes NSE as an acidic protease specific to neurons and neuroendocrine cells, and as the most sensitive and specific tumour marker for small-cell lung cancer (SCLC).
- Cancer antigen 72-4 (CA72-4)
- Hospital-listed purpose: Screening for malignancies including lung, gastric, pancreatic, biliary, colon, breast and ovarian cancer.
- Beta subunit of human chorionic gonadotropin (β-hCG)
- Hospital-listed purpose: A glycoprotein secreted by placental trophoblast cells that promotes gonadal development; the sheet lists it as a marker of choriocarcinoma.
- Ferritin
- Hospital-listed purpose: A non-specific tumour marker reflecting stored ferritin and the amount of stored iron.
Ultrasound examinations
- Echocardiography
- Hospital-listed purpose: The sheet describes cardiac colour Doppler ultrasound as the only method that dynamically displays intracardiac structures, heartbeat and blood flow without injury to the body. For coronary heart disease, it visualises myocardial movement and cardiac function and can indicate areas of myocardial ischaemia.
- Carotid colour Doppler ultrasound
- Hospital-listed purpose: Displays carotid intima-media thickening, plaque presence, location and size, the presence and degree of stenosis, and occlusion. It also allows measurement and localisation, and analysis of arterial blood flow dynamics.
- Thyroid colour Doppler ultrasound
- Hospital-listed purpose: To observe thyroid masses, nodules, enlargement and inflammation.
- Abdominal colour Doppler ultrasound
- Hospital-listed purpose: Provides dynamic colour ultrasound images to assess the liver, gallbladder, spleen, pancreas and kidneys.
- Urinary system colour Doppler ultrasound
- Hospital-listed purpose: Examines prostate shape and size and provides diagnostic information for prostatic hyperplasia, enlargement and calcification.
CT and magnetic resonance imaging
- Chest CT
- Hospital-listed purpose: To assess lung disease, including inflammatory changes and space-occupying lesions.
- Brain MRI
- Hospital-listed purpose: To identify brain lesions; the sheet describes a high diagnostic confirmation rate for low-grade astrocytoma, ganglion-related lesions, glioma, arteriovenous malformations and haematoma.
- Brain magnetic resonance angiography (MRA)
- Hospital-listed purpose: Mainly used to diagnose cerebrovascular lesions.
Functional examination
- Electrocardiogram (ECG)
- Hospital-listed purpose: To identify abnormal cardiac function.
Gastroscopy and colonoscopy
- Sedated gastroscopy and colonoscopy
- Performed personally by a specialist from Friendship Hospital, as stated in the quotation sheet.
Source: Beijing Puhua International Hospital health screening quotation sheets. Hospital-listed purpose notes are translated from the original sheets.
Women’s Health Screening Package
CNY 20,422 (Approx. $2,917 USD)
Eye examination
- Eye examination package
- Visual acuity test
- Intraocular pressure measurement
- Computerised refraction and corneal curvature measurement
- Axial length measurement (optical biometry)
- Clinical refraction
- Fundus examination
- Macular optical coherence tomography (OCT)
Gynaecological examinations
- Gynaecological internal examination
- Internal examination by a gynaecologist.
- Thin-layer cervical cytology (TCT)
- Hospital-listed purpose: Mainly used for cervical cancer and precancerous lesion screening.
- Human papillomavirus (HPV) test
- Hospital-listed purpose: To determine whether HPV infection is present.
Laboratory tests
- Five infectious disease tests
- Hepatitis A, hepatitis B, hepatitis C, syphilis and HIV.
- Routine urinalysis
- Hospital-listed purpose: May indicate urinary system disorders, including acute or chronic nephritis, pyelonephritis, cystitis, urethritis, nephrotic syndrome, lupus nephritis, haemoglobinuria, renal infarction, acute renal tubular necrosis caused by heavy metal salts or medications, kidney or bladder tumours, and glucose in the urine.
- Electrolyte panel (3 items)
- Hospital-listed purpose: To assess electrolyte metabolism disturbances associated with conditions such as kidney disease, diabetes and endocrine disorders.
- Kidney function panel (4 items)
- Hospital-listed purpose: May indicate impaired kidney function, including in conditions such as pyelonephritis, renal tuberculosis and kidney tumours.
- Liver function panel (9 items)
- Hospital-listed purpose: Sensitive indicators of liver cell injury. Elevated results may indicate liver or biliary disease, including acute infectious hepatitis, toxic hepatitis and drug-induced toxic hepatitis.
- Blood lipid panel (4 items)
- Hospital-listed purpose: Blood lipid concentrations are closely associated with cardiovascular and cerebrovascular disease and provide reference information for diagnosing atherosclerosis, coronary heart disease and nephrotic syndrome. The sheet also lists risk indication and diagnosis for atherosclerosis, hypertension, cerebrovascular disease, coronary heart disease, diabetes, obesity, hyperlipidaemia and nephrotic syndrome.
- Cardiac enzyme panel (4 items)
- Hospital-listed purpose: To assist in the diagnosis of myocardial infarction, myocarditis and other cardiac conditions.
- Calcium and phosphorus
- Hospital-listed purpose: To check for chronic kidney disease.
- Blood glucose
- Hospital-listed purpose: To assess low blood glucose, diabetes and blood glucose control.
- Carbon-14 urea breath test
- Hospital-listed purpose: To determine whether bacterial infection is present in the stomach; the sheet links this infection with gastritis and gastric cancer.
- Glycated haemoglobin (HbA1c)
- Hospital-listed purpose: Reflects average blood glucose levels over the preceding 2–3 months.
- Homocysteine
- Hospital-listed purpose: Mainly used to assess conditions such as coronary atherosclerotic heart disease, myocardial infarction and cerebral infarction.
- Coagulation panel (4 items)
- Hospital-listed purpose: Reflects coagulation function and is used to investigate thrombotic disease.
- Plasma D-dimer
- Hospital-listed purpose: To assess the risk of deep vein thrombosis.
- Thyroid function panel (7 items)
- Triiodothyronine (T3)
- Thyroxine (T4)
- Serum thyroid-stimulating hormone (TSH)
- Serum free T3
- Serum free T4
- Anti-thyroglobulin antibodies
- Anti-thyroid peroxidase antibodies
- Hospital-listed purpose: To assess thyroid function and thyroid autoimmune status.
Women’s C12 tumour marker panel
- Alpha-fetoprotein (AFP)
- Hospital-listed purpose: To assist in the diagnosis of liver cancer.
- Carcinoembryonic antigen (CEA)
- Hospital-listed purpose: Early diagnosis of rectal and colorectal cancer.
- Cancer antigen 19-9 (CA19-9)
- Hospital-listed purpose: Early diagnosis of digestive system disease, pancreatic cancer and biliary malignancies.
- Cancer antigen 125 (CA125)
- Hospital-listed purpose: The sheet describes relatively high sensitivity for several tumours, including ovarian, liver, lung and colorectal cancer.
- Cancer antigen 15-3 (CA15-3)
- Hospital-listed purpose: Mainly used in the diagnosis of breast cancer.
- Serum marker “血清骨胶素 (CY211)”
- Hospital-listed purpose: To detect lung tumours.
- Cancer antigen 242 (CA242)
- Hospital-listed purpose: A broad-spectrum digestive tract tumour marker.
- Cancer antigen 50 (CA50)
- Hospital-listed purpose: An indicator for tumours including liver, lung, pancreatic, gastric, ovarian, gallbladder, breast, colon and rectal cancer. The sheet describes it as a non-specific, broad-spectrum tumour marker.
- Neuron-specific enolase (NSE)
- Hospital-listed purpose: The sheet describes NSE as an acidic protease specific to neurons and neuroendocrine cells, and as the most sensitive and specific tumour marker for small-cell lung cancer (SCLC).
- Cancer antigen 72-4 (CA72-4)
- Hospital-listed purpose: Screening for malignancies including lung, gastric, pancreatic, biliary, colon, breast and ovarian cancer.
- Beta subunit of human chorionic gonadotropin (β-hCG)
- Hospital-listed purpose: A glycoprotein secreted by placental trophoblast cells that promotes gonadal development; the sheet lists it as a marker of choriocarcinoma.
- Ferritin
- Hospital-listed purpose: A non-specific tumour marker reflecting stored ferritin and the amount of stored iron.
Ultrasound examinations
- Echocardiography
- Hospital-listed purpose: The sheet describes cardiac colour Doppler ultrasound as the only method that dynamically displays intracardiac structures, heartbeat and blood flow without injury to the body. For coronary heart disease, it visualises myocardial movement and cardiac function and can indicate areas of myocardial ischaemia.
- Carotid colour Doppler ultrasound
- Hospital-listed purpose: Displays carotid intima-media thickening, plaque presence, location and size, the presence and degree of stenosis, and occlusion. It also allows measurement and localisation, and analysis of arterial blood flow dynamics.
- Thyroid colour Doppler ultrasound
- Hospital-listed purpose: To observe thyroid masses, nodules, enlargement and inflammation.
- Abdominal colour Doppler ultrasound
- Hospital-listed purpose: Provides dynamic colour ultrasound images to assess the liver, gallbladder, spleen, pancreas and kidneys.
- Breast ultrasound
- Hospital-listed purpose: To assess breast conditions such as breast cancer and mastitis.
- Transvaginal colour Doppler ultrasound
- Hospital-listed purpose: To assess abnormalities of the uterus, ovaries and pelvis.
CT and magnetic resonance imaging
- Chest CT
- Hospital-listed purpose: To assess lung disease, including inflammatory changes and space-occupying lesions.
- Brain MRI
- Hospital-listed purpose: To identify brain lesions; the sheet describes a high diagnostic confirmation rate for low-grade astrocytoma, ganglion-related lesions, glioma, arteriovenous malformations and haematoma.
- Brain magnetic resonance angiography (MRA)
- Hospital-listed purpose: Mainly used to diagnose cerebrovascular lesions.
Functional examination
- Electrocardiogram (ECG)
- Hospital-listed purpose: To identify abnormal cardiac function.
Gastroscopy and colonoscopy
- Sedated gastroscopy and colonoscopy
- Performed personally by a specialist from Friendship Hospital, as stated in the quotation sheet.
Source: Beijing Puhua International Hospital health screening quotation sheets. Hospital-listed purpose notes are translated from the original sheets.
**Disclaimer: The USD price is an estimate only for your convenience (based on 1 USD ≈ 7RMB). The actual USD amount will vary based on your bank's exchange rate at the time of transaction.
Speak to Your China Medical Concierge
Beijing Puhua International Hospital is located at No. 12, Tiantan Nanli, Dongcheng District, Beijing. Both packages listed above include eye examinations, laboratory tests, C12 tumour marker panels, ultrasound, chest CT, brain MRI and MRA, ECG, and sedated gastroscopy and colonoscopy.
Men-specific items include free PSA, total PSA, the free-to-total PSA ratio and urinary system ultrasound. The women’s package includes a gynaecological internal examination, TCT and HPV tests, breast ultrasound and transvaginal ultrasound. The full comparison lists the individual tests within each package.
Confirm current prices, inclusions, availability, preparation requirements, endoscopy arrangements and any additional fees with the hospital before booking. MedBridgeNZ supports enquiries, appointment coordination, translation of medical records and non-clinical travel logistics. MedBridgeNZ does not provide medical advice, diagnosis or treatment. A qualified healthcare professional should assess which examinations are appropriate for you.
Free initial enquiry · No obligation · Your information is handled confidentially
bottom of page